COR Q2 2022 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q2 2022 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$57.7B+17.4% YoY

Gross Profit

$2.1B3.6% margin

Operating Income

$857M1.5% margin

Net Income

$548M0.9% margin

EPS (Diluted)

$2.59

QoQ Revenue Growth

-3.2%

Cash Flow

Operating Cash Flow

$267M

Free Cash Flow

$137M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$57.3B

Total Liabilities

$56.4B

Stockholders' Equity

$550M

Cash & Equivalents

$3.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57.7B	$49.2B	+17.4%
Gross Profit	$2.1B	$1.4B	+43.8%
Operating Income	$857M	$703M	+21.9%
Net Income	$548M	$435M	+25.9%

Revenue Segments

Pharmaceutical Distribution

$49.8B86%

International Healthcare Solutions

$6.8B12%

Animal Health

$1.2B2%

Geographic Segments

U.S. Healthcare Solutions

$50.9B88%

International Healthcare Solutions

$6.8B12%